Emerging infectious diseases · 2020 · 14 citations · 13 references
Life SciencesInfectious DiseasesMicrobiologyMedical MicrobiologyMolecular VirologyVirologyTransfusion-transmitted InfectionsViral HepatitisHepatitis E Virus InfectionInfectious HepatitisPlasma SafetyTransfusion-transmitted Infection TestingTransfusion-transmitted Viral InfectionsViral Hepatitis TransmissionViral Risk AssessmentViral Safety Evaluation
Hepatitis E has emerged as a major transfusion-transmitted infectious risk. Two recipients of plasma from 2 lots (A and B) of pooled solvent/detergent-treated plasma were found to be infected by hepatitis E virus (HEV) that was determined to have been transmitted by the solvent/detergent-treated plasma. HEV RNA viral loads were 433 IU in lot A and 55 IU in lot B. Retrospective studies found that 100% (13/13) of evaluable lot A recipients versus 18% (3/17) of evaluable lot B recipients had been infected by HEV (p<0.001), albeit not necessarily at time of transfusion. Among evaluable recipients, 86% with a transfused HEV RNA load >50,000 IU were infected, most likely by the HEV-containing solvent/detergent-treated plasma, versus only 7% with a transfused HEV RNA load <50,000 IU (p<0.001). Overall, solvent/detergent-treated plasma might harbor HEV. Such an occurrence might result in a dose-dependent risk for transfusion-transmitted hepatitis E.
13
A nationwide survey of hepatitis E viral infection in French blood donors
Jean‐Michel Mansuy, Pierre Gallian, Chloé Dimeglio et al. · Hepatology · 2016 · 226 citations
Hepatitis E Virus Genotype 3 Diversity, France
Florence Abravanel, Jean‐Michel Mansuy, Martine Dubois et al. · Emerging infectious diseases · 2008 · 148 citations · Full text
Hepatitis E Virus Infections in Blood Donors, France
Pierre Gallian, Sébastien Lhomme, Y. Piquet et al. · Emerging infectious diseases · 2014 · 143 citations · Full text